Table 4. Incidence of DILI by causative agent.
Causative agents | DILI (Number) | Total No. of prescribed patients† during the study period (Number) | Crude incidence of DILI (%) per 1,000 prescribed patients* | 95% CI |
---|---|---|---|---|
Piperacillin-tazobactam | 38 | 12,001 | 3.2 | 2.2–4.2 |
Methotrexate | 31 | 1,596 | 19.4 | 12.7–26.2 |
Acetaminophen | 29 | 73,262 | 0.4 | 0.3–0.5 |
Ceftriaxone | 25 | 21,838 | 1.2 | 0.7–1.6 |
TPN | 24 | 26,591 | 0.9 | 0.5–1.3 |
Vancomycin | 16 | 6,899 | 2.3 | 1.2–3.5 |
Meropenem | 14 | 5,307 | 2.6 | 1.3–4.0 |
Cytosine arabinoside | 11 | 597 | 18.4 | 7.6–29.2 |
DILI, drug-induced liver injury; CI, confidence interval; TPN, total parental nutrition.
*,†Prescribed patients were those who were prescribed the drug of interest more than once regardless of the occurrence of DILI.